What is ADTX's earnings growth forecast for 2025-2025?
(NASDAQ: ADTX) Aditxt's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Aditxt's earnings in 2025 is -$36,948,279.
In 2025, ADTX is forecast to generate -$1,258,869,353 in earnings, with the lowest earnings forecast at -$1,209,501,927 and the highest earnings forecast at -$1,295,894,922.
What is ADTX's revenue growth forecast for 2025-2025?
(NASDAQ: ADTX) Aditxt's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Aditxt's revenue in 2025 is $12,051.
In 2025, ADTX is forecast to generate $105,811,512 in revenue, with the lowest revenue forecast at $101,661,066 and the highest revenue forecast at $108,921,859.
What is ADTX's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: ADTX) forecast ROA is -3,850.79%, which is lower than the forecast US Biotechnology industry average of 12.84%.
What is ADTX's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: ADTX) Aditxt's current Earnings Per Share (EPS) is $99,873.92. In 2025, ADTX's EPS is forecast to hit -$252.96 (min: -$243.04, max: -$260.40).
What is ADTX's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: ADTX) forecast ROE is -9,714.21%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.